Works matching IS 14712210 AND DT 2012 AND VI 12 AND IP 1

Results: 8

Novel olanzapine analogues presenting a reduced H1 receptor affinity and retained 5HT2A/D2 binding affinity ratio.

Published in:

BMC Pharmacology, 2012, v. 12, n. 1, p. 8, doi. 10.1186/1471-2210-12-8

By:

Jafari, Somayeh;
Bouillon, Marc E.;
Xu-Feng Huang;
Pyne, Stephen G.;
Fernandez-Enright, Francesca

Publication type:

Article

Lipid phosphate phosphatase inhibitors locally amplify lysophosphatidic acid LPA1 receptor signalling in rat brain cryosections without affecting global LPA degradation.

Published in:

BMC Pharmacology, 2012, v. 12, n. 1, p. 7, doi. 10.1186/1471-2210-12-7

By:

Aaltonen, Niina;
Lehtonen, Marko;
Varonen, Katri;
Arrufat Goterris, Gemma;
Laitinen, Jarmo T.

Publication type:

Article

The orthosteric agonist 2-chloro-5-hydroxyphenylglycine activates mGluR5 and mGluR1 with similar efficacy and potency.

Published in:

BMC Pharmacology, 2012, v. 12, n. 1, p. 6, doi. 10.1186/1471-2210-12-6

By:

Kammermeier, Paul J.

Publication type:

Article

Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity.

Published in:

BMC Pharmacology, 2012, v. 12, n. 1, p. 5, doi. 10.1186/1471-2210-12-5

By:

Munro, Thomas A.;
Berry, Loren M;
Van't Veer, Ashlee;
B�guin, C�cile;
Carroll, F. Ivy;
Zhao, Zhiyang;
Carlezon Jr, William A.;
Cohen, Bruce M.

Publication type:

Article

5-hydroxytryptamine (5-HT) reduces total peripheral resistance during chronic infusion: direct arterial mesenteric relaxation is not involved.

Published in:

BMC Pharmacology, 2012, v. 12, n. 1, p. 4, doi. 10.1186/1471-2210-12-4

By:

Davis, Robert Patrick;
Pattison, Jill;
Thompson, Janice M.;
Tiniakov, Ruslan;
Scrogin, Karie E.;
Watts, Stephanie W.

Publication type:

Article

Contrasting effects of linaclotide and lubiprostone on restitution of epithelial cell barrier properties and cellular homeostasis after exposure to cell stressors.

Published in:: BMC Pharmacology, 2012, v. 12, n. 1, p. 3, doi. 10.1186/1471-2210-12-3
Publication type:: Article

Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor.

Published in:: BMC Pharmacology, 2012, v. 12, n. 1, p. 2, doi. 10.1186/1471-2210-12-2
Publication type:: Article

Computational models for in-vitro anti-tubercular activity of molecules based on high-throughput chemical biology screening datasets.

Published in:

BMC Pharmacology, 2012, v. 12, n. 1, p. 1, doi. 10.1186/1471-2210-12-1

By:

Periwal, Vinita;
Kishtapuram, Shireesha;
Scaria, Vinod

Publication type:

Article

Works matching IS 14712210 AND DT 2012 AND VI 12 AND IP 1

Novel olanzapine analogues presenting a reduced H<sub>1</sub> receptor affinity and retained 5HT<sub>2A</sub>/D<sub>2</sub> binding affinity ratio.

Lipid phosphate phosphatase inhibitors locally amplify lysophosphatidic acid LPA<sub>1</sub> receptor signalling in rat brain cryosections without affecting global LPA degradation.

The orthosteric agonist 2-chloro-5-hydroxyphenylglycine activates mGluR5 and mGluR1 with similar efficacy and potency.

Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity.

5-hydroxytryptamine (5-HT) reduces total peripheral resistance during chronic infusion: direct arterial mesenteric relaxation is not involved.

Contrasting effects of linaclotide and lubiprostone on restitution of epithelial cell barrier properties and cellular homeostasis after exposure to cell stressors.

Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor.

Computational models for in-vitro anti-tubercular activity of molecules based on high-throughput chemical biology screening datasets.